Farmak supported the conduct of the 25th Congress of Surgeons of Ukraine dedicated to the 100th anniversary since the birth of Academician O. Shalimov.
The 25th Congress of Surgeons of Ukraine, a scientific and practical forum of nation-wide significance, was held recently. The congress served as platform for exchanging experience by domestic and foreign specialists: general surgeons, cardiovascular surgeons, transplantologists, pediatric surgeons, plastic surgeons, combustiologists, and endocrinologists.
Farmak JSC was the main sponsor of the event and provided support for its conduct.
“As the industry leader caring about the quality of our products for the health of Ukrainians, we believe that it is extremely important to develop domestic medical science. Undoubtedly, a socially responsible business should support scientific conferences and contribute to their conduct in Ukraine with the participation of the world’s best representatives. That is why, Farmak supported the 25th Congress of Surgeons of Ukraine bringing together about 2,000 surgical specialists of both domestic and international level”, noted Susana Khalilova, Marketing and Sales Director of Farmak JSC.
During the congress, plenary sessions dedicated to the treatment of gunshot injuries due to military actions; modern technologies of surgical correction of digestive pathologies; analysis of the current state of public surgical care and tasks to improve its organization; and consideration of organizational issues were held. The leading specialists in the field held sectional sessions on early postoperative complications; current state and problems of cardiovascular, pediatric, endocrine, bariatric, plastic surgery, combustiology, and transplantation.
Please see Farmak’s special video from the congress below:
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]
The Memorandum is aimed at developing the mutual cooperation in the implementation of the state programs of the Republic of Uzbekistan for the further development of the national pharmaceutical industry. “We know the Uzbek market well and we are committed to develop cooperation. Farmak has been present in Uzbekistan since 2004. The residents of this [&hellip...